1 2 3 4 5 6 7 CHEMI S.p.A. is a leading company in the chemical-pharmaceutical area, made up of people who strive every day to bring health to the service of all through research, technological innovation and passion. Leadership based on science, manufacturing and commercialization. We belong to the Italfarmaco Group and are specialized in the development, production and sales of high quality generic APIs , complex to make generics, peptides, lipids and phospholipids. We offer unique and competitive services in the production of “evergreen” APIs. We are leader in the manufacture and characterization of complex molecules, managing end to end extremely sophisticated projects in collaboration with our partners and with the companies in the Group, to solve the unmeet medical needs in several therapeutical areas. Competence, innovative solutions, production processes, technological implementation are the key factors of our success. We work on daily basis to strive company sustainability through the right company's values and behaviors. We constantly invest in new generation of talent to pay greater attention to developing and passing on knowledge. Our mission is to look to the future, living in the present without forgetting the past. FIND OUT MORE ABOUT OUR WORLD CODICE ETICO General Part Special Part CHEMI S.P.A. Via dei lavoratori 54 20092 Cinisello Balsamo (Milano) ITALY Phone: +39 02 64 43 1 / Fax: +39 02 6128 960 Copyright 2015 CHEMI S.p.A. Privacy Policy By continuing to browse this website, you are agreeing for us to store cookies where required to provide better browsing experience of our website ACCEPT Read More Coronavirus disease (COVID – 19). Measures taken by the Company for the safeguard of the health and safety of associates and patients. As the Coronavirus (COVID-19) continues to spread globally, the Company has adopted some measures for the health and safety of associates and patients. Effective March 16 2020, mostly of the associates of the Company are requested to work from home, with the exception of those working in laboratories and manufacturing sites, with segregation and shift, reduction of the access to the sites and offices. Additional measures are taken accordingly to Authorities’ provisions. The Company remains responsive to any development regarding coronavirus and will take all necessary steps to protect its associates and patients as the situation evolves. COMPANY REGULATIONS : SEGREGATION AND STAFF TURNOVER IN OFFICES. REGULATION FOR ACCESS BY EXTERNAL SUPPLIERS REGOLAMENTO COVID FASE 2 INTEGRAZIONE APPALTO SERVIZI MISURE CONTENIMENTO CONTAGIO FASE2 PROTOCOLLO RILEVAZIONE TEMPERATURA CORPOREA